Suppr超能文献

Aurora-A 表达在人膀胱癌中的预后意义。

Prognostic significance of Aurora-A expression in human bladder cancer.

机构信息

Tianjin Unode Laboratory of Basic Medical Urology, Tianjin Institute of Urology, Department of Urology, the Second Hospital of Tianjin Medical University, PR China.

出版信息

Acta Histochem. 2011 Sep;113(5):514-8. doi: 10.1016/j.acthis.2010.05.004. Epub 2010 Jul 2.

Abstract

Aurora-A is an oncogenic serine/threonine kinase, which plays important roles in tumorigenesis, development and chemoresistance of human cancers. The aim of the study was to detect the expression of Aurora-A gene in bladder cancer tissues and analyze its association with prognosis of bladder cancer patients. RT-PCR was performed to detect the expression of Aurora-A mRNA in 20 cases of bladder cancer and corresponding non-tumor tissue samples. Immunohistochemistry was performed to detect the localization of Aurora-A protein in 96 cases of bladder cancer tissue samples. Associations between Aurora-A protein expression and clinico-pathological factors or survival of bladder cancer patients were statistically analyzed. It was found that the expression levels of Aurora-A mRNA in bladder cancer tissues (1.08±0.24) were significantly higher than those in corresponding non-tumor tissues (0.22±0.07; P<0.01). Moreover, immunohistochemical staining results showed the localization of Aurora-A protein to be mainly located in the cytoplasm of bladder cancer cells. High levels of Aurora-A protein expression were correlated with pathological stage (P=0.007), lymph node metastasis (P=0.014) and venous invasion (P=0.008), but not with other factors including age, gender, tumor grade and recurrence of superficial cancer. Patients with high expression levels of Aurora-A protein showed lower disease-free and overall survival rates than those with low expression levels (P=0.0072 and 0.0009, respectively). Univariate and multivariate analysis of prognostic factors in bladder cancer patients indicated that Aurora-A expression was an independent unfavorable prognostic factor (hazard ratio: 0.673; 95% confidence interval: 0.388-0.912; P<0.001). Our study suggests that overexpression of Aurora-A gene may play an important role in the progression of bladder cancer and that Aurora-A expression is an independent factor for predicting the prognosis of bladder cancer in patients.

摘要

Aurora-A 是一种致癌的丝氨酸/苏氨酸激酶,在人类癌症的发生、发展和化疗耐药中发挥重要作用。本研究旨在检测膀胱癌组织中 Aurora-A 基因的表达,并分析其与膀胱癌患者预后的关系。采用 RT-PCR 检测 20 例膀胱癌及相应非肿瘤组织样本中 Aurora-A mRNA 的表达。采用免疫组织化学法检测 96 例膀胱癌组织样本中 Aurora-A 蛋白的定位。统计分析 Aurora-A 蛋白表达与膀胱癌患者临床病理因素及生存的关系。结果发现,膀胱癌组织中 Aurora-A mRNA 的表达水平(1.08±0.24)明显高于相应非肿瘤组织(0.22±0.07;P<0.01)。此外,免疫组化染色结果显示 Aurora-A 蛋白主要定位于膀胱癌细胞质中。Aurora-A 蛋白高表达与病理分期(P=0.007)、淋巴结转移(P=0.014)和静脉侵犯(P=0.008)有关,而与其他因素如年龄、性别、肿瘤分级和表浅癌复发无关。Aurora-A 蛋白高表达患者的无病生存率和总生存率均低于低表达患者(P=0.0072 和 0.0009)。膀胱癌患者预后因素的单因素和多因素分析表明,Aurora-A 表达是独立的不良预后因素(危险比:0.673;95%置信区间:0.388-0.912;P<0.001)。本研究表明,Aurora-A 基因的过表达可能在膀胱癌的进展中起重要作用,Aurora-A 表达是预测膀胱癌患者预后的独立因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验